Entrada Therapeutics Inc.
(TRDA)
undefined
undefined%
At close: undefined
17.66
-0.11%
After-hours Dec 13, 2024, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -6.68M | -94.62M | -51.16M | -26.52M | -5.10M |
| Depreciation & Amortization | 2.84M | 1.90M | 1.12M | 326.00K | 104.00K |
| Stock-Based Compensation | 13.11M | 9.89M | 2.53M | 325.00K | 294.00K |
| Other Working Capital | 139.12M | -16.40M | -2.71M | -349.00K | -193.00K |
| Other Non-Cash Items | -5.78M | 151.00K | 74.00K | 20.00K | -6.27M |
| Deferred Income Tax | - | - | - | - | - |
| Change in Working Capital | 136.31M | -11.11M | -3.42M | 282.00K | 174.00K |
| Operating Cash Flow | 139.80M | -93.79M | -50.86M | -25.57M | -10.80M |
| Capital Expenditures | -5.61M | -2.89M | -4.58M | -2.33M | -630.00K |
| Acquisitions | - | 145.76M | - | 7.00K | - |
| Purchase of Investments | -407.21M | -221.98M | - | - | - |
| Sales Maturities Of Investments | 274.43M | 76.21M | - | - | - |
| Other Investing Acitivies | - | -145.76M | - | - | - |
| Investing Cash Flow | -138.40M | -148.65M | -4.58M | -2.32M | -630.00K |
| Debt Repayment | - | - | - | - | - |
| Common Stock Repurchased | - | 284.00K | - | - | - |
| Dividend Paid | - | - | - | - | - |
| Other Financial Acitivies | 1.63M | 479.00K | 116.77M | 50.09M | 38.00K |
| Financial Cash Flow | 21.04M | 479.00K | 307.46M | 50.09M | 38.00K |
| Net Cash Flow | 22.45M | -241.96M | 252.02M | 22.20M | -11.39M |
| Free Cash Flow | 134.19M | -96.67M | -55.44M | -27.89M | -11.43M |